Skip to main content

Find Clinical Trials

Home
Conditions
Determine Minimally to Moderately Infective Dose (MMID) of Influenza A H3N2

Clinical trial condition

Determine Minimally to Moderately Infective Dose (MMID) of Influenza A H3N2

Explore clinical trials studying Determine Minimally to Moderately Infective Dose (MMID) of Influenza A H3N2. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies

Refine in advanced search Browse all conditions

Determine Minimally to Moderately Infective Dose (MMID) of Influenza A H3N2 trial results

Completed

Influenza A H3N2 Human Challenge Study in Healthy Adult Volunteers

NCT02594189

Conditions: Determine Minimally to Moderately Infective Dose (MMID) of Influenza A H3N2, Infections, Influenza, Human, +5 more
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States

View Trial Details